US › Healthcare

Sight Sciences Inc (SGHT)

US · Healthcare · Medical Devices

$5.64+1.99%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$19.7M
Revenue YoY
+12.5%
Net profit
$-13.0M
Profit YoY
+8.3%
EPS
$-0.24
EPS estimate
$-0.20
Net margin
-65.9%

EPS came in at -0.24 against a street estimate of -0.20 — a miss of 20.0%.

Key statistics

Market cap
$300.9M
Forward P/E
0.0
P/B
5.31
Book value
$1.00
EPS (TTM)
$-0.70
52-week high
$9.24
52-week low
$3.19
50-day MA
$5.09
200-day MA
$5.54
Beta
2.42

Analyst view

Analysts rate Sight Sciences Inc a buy (2 buy, 6 hold, 0 sell out of 8) with an average price target of $8.40.

Shareholding

Insiders
19.98%
Institutions
53.54%

Largest institutional holders

FundStake
Long Focus Capital Management, LLC6.61%
BlackRock Inc5.21%
Pathstone Holdings LLC4.41%
Americana Partners, LLC3.09%
Vanguard Capital Management, LLC2.67%
B Group, Inc1.78%
Geode Capital Management, LLC1.68%
State Street Corp1.53%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Sight Sciences Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.